Sister chromatid exchanges in lymphocyte cultures of patients previously treated with dibromodulcitol

Stephen Maxted Ansell, C. E. Jansen Van Rensburg, B. L. Rapoport, P. Gresse, E. V. Cloete, A. M. Van Staden, K. Stevens, C. I. Falkson, G. Falkson

Research output: Contribution to journalArticle

Abstract

Acute non-lymphatic leukaemia and myelodysplasia occur in a larger percentage of patients treated with dibromodulcitol (DBD) than in patients treated with other cytostatics. Sister chromatid exchanges (SCE) in the lymphocytes in peripheral blood as well as other haematological parameters were measured in women with breast cancer to investigate whether women who had previously been treated with DBD as a part of their treatment regime had an increased frequency of SCE or another haematological abnormality attributable to DBD. SCE levels were elevated in women treated with DBD as well as in those treated with other cytostatics compared to the untreated control group. All other haematological parameters were normal. There was no significant difference in the number of SCEs between the patients who received DBD and those treated with other cytostatics. The increased frequencies of SCE in the treated patients are attributable to various cytostatic agents, and there is no significant permanent increase in the frequency of SCE after exposure to DBD.

Original languageEnglish (US)
Pages (from-to)253-257
Number of pages5
JournalOncology
Volume48
Issue number3
StatePublished - 1991
Externally publishedYes

Fingerprint

Mitolactol
Sister Chromatid Exchange
Cytostatic Agents
Lymphocytes
Leukemia
Breast Neoplasms
Control Groups

Keywords

  • acute non-lymphatic leukaemia
  • breast cancer
  • dibromodulcitol
  • myelodysplasia
  • sister chromatid exchanges

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ansell, S. M., Jansen Van Rensburg, C. E., Rapoport, B. L., Gresse, P., Cloete, E. V., Van Staden, A. M., ... Falkson, G. (1991). Sister chromatid exchanges in lymphocyte cultures of patients previously treated with dibromodulcitol. Oncology, 48(3), 253-257.

Sister chromatid exchanges in lymphocyte cultures of patients previously treated with dibromodulcitol. / Ansell, Stephen Maxted; Jansen Van Rensburg, C. E.; Rapoport, B. L.; Gresse, P.; Cloete, E. V.; Van Staden, A. M.; Stevens, K.; Falkson, C. I.; Falkson, G.

In: Oncology, Vol. 48, No. 3, 1991, p. 253-257.

Research output: Contribution to journalArticle

Ansell, SM, Jansen Van Rensburg, CE, Rapoport, BL, Gresse, P, Cloete, EV, Van Staden, AM, Stevens, K, Falkson, CI & Falkson, G 1991, 'Sister chromatid exchanges in lymphocyte cultures of patients previously treated with dibromodulcitol', Oncology, vol. 48, no. 3, pp. 253-257.
Ansell SM, Jansen Van Rensburg CE, Rapoport BL, Gresse P, Cloete EV, Van Staden AM et al. Sister chromatid exchanges in lymphocyte cultures of patients previously treated with dibromodulcitol. Oncology. 1991;48(3):253-257.
Ansell, Stephen Maxted ; Jansen Van Rensburg, C. E. ; Rapoport, B. L. ; Gresse, P. ; Cloete, E. V. ; Van Staden, A. M. ; Stevens, K. ; Falkson, C. I. ; Falkson, G. / Sister chromatid exchanges in lymphocyte cultures of patients previously treated with dibromodulcitol. In: Oncology. 1991 ; Vol. 48, No. 3. pp. 253-257.
@article{1072810ad6f84d839be5459a68bc150e,
title = "Sister chromatid exchanges in lymphocyte cultures of patients previously treated with dibromodulcitol",
abstract = "Acute non-lymphatic leukaemia and myelodysplasia occur in a larger percentage of patients treated with dibromodulcitol (DBD) than in patients treated with other cytostatics. Sister chromatid exchanges (SCE) in the lymphocytes in peripheral blood as well as other haematological parameters were measured in women with breast cancer to investigate whether women who had previously been treated with DBD as a part of their treatment regime had an increased frequency of SCE or another haematological abnormality attributable to DBD. SCE levels were elevated in women treated with DBD as well as in those treated with other cytostatics compared to the untreated control group. All other haematological parameters were normal. There was no significant difference in the number of SCEs between the patients who received DBD and those treated with other cytostatics. The increased frequencies of SCE in the treated patients are attributable to various cytostatic agents, and there is no significant permanent increase in the frequency of SCE after exposure to DBD.",
keywords = "acute non-lymphatic leukaemia, breast cancer, dibromodulcitol, myelodysplasia, sister chromatid exchanges",
author = "Ansell, {Stephen Maxted} and {Jansen Van Rensburg}, {C. E.} and Rapoport, {B. L.} and P. Gresse and Cloete, {E. V.} and {Van Staden}, {A. M.} and K. Stevens and Falkson, {C. I.} and G. Falkson",
year = "1991",
language = "English (US)",
volume = "48",
pages = "253--257",
journal = "Oncology",
issn = "0030-2414",
publisher = "UBM Medica Healthcare Publications",
number = "3",

}

TY - JOUR

T1 - Sister chromatid exchanges in lymphocyte cultures of patients previously treated with dibromodulcitol

AU - Ansell, Stephen Maxted

AU - Jansen Van Rensburg, C. E.

AU - Rapoport, B. L.

AU - Gresse, P.

AU - Cloete, E. V.

AU - Van Staden, A. M.

AU - Stevens, K.

AU - Falkson, C. I.

AU - Falkson, G.

PY - 1991

Y1 - 1991

N2 - Acute non-lymphatic leukaemia and myelodysplasia occur in a larger percentage of patients treated with dibromodulcitol (DBD) than in patients treated with other cytostatics. Sister chromatid exchanges (SCE) in the lymphocytes in peripheral blood as well as other haematological parameters were measured in women with breast cancer to investigate whether women who had previously been treated with DBD as a part of their treatment regime had an increased frequency of SCE or another haematological abnormality attributable to DBD. SCE levels were elevated in women treated with DBD as well as in those treated with other cytostatics compared to the untreated control group. All other haematological parameters were normal. There was no significant difference in the number of SCEs between the patients who received DBD and those treated with other cytostatics. The increased frequencies of SCE in the treated patients are attributable to various cytostatic agents, and there is no significant permanent increase in the frequency of SCE after exposure to DBD.

AB - Acute non-lymphatic leukaemia and myelodysplasia occur in a larger percentage of patients treated with dibromodulcitol (DBD) than in patients treated with other cytostatics. Sister chromatid exchanges (SCE) in the lymphocytes in peripheral blood as well as other haematological parameters were measured in women with breast cancer to investigate whether women who had previously been treated with DBD as a part of their treatment regime had an increased frequency of SCE or another haematological abnormality attributable to DBD. SCE levels were elevated in women treated with DBD as well as in those treated with other cytostatics compared to the untreated control group. All other haematological parameters were normal. There was no significant difference in the number of SCEs between the patients who received DBD and those treated with other cytostatics. The increased frequencies of SCE in the treated patients are attributable to various cytostatic agents, and there is no significant permanent increase in the frequency of SCE after exposure to DBD.

KW - acute non-lymphatic leukaemia

KW - breast cancer

KW - dibromodulcitol

KW - myelodysplasia

KW - sister chromatid exchanges

UR - http://www.scopus.com/inward/record.url?scp=0025844968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025844968&partnerID=8YFLogxK

M3 - Article

C2 - 2023706

AN - SCOPUS:0025844968

VL - 48

SP - 253

EP - 257

JO - Oncology

JF - Oncology

SN - 0030-2414

IS - 3

ER -